These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21116070)

  • 1. Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation.
    Shiga T; Kinugawa K; Hatano M; Yao A; Nishimura T; Endo M; Kato N; Hirata Y; Kyo S; Ono M; Nagai R
    Circ J; 2011; 75(1):121-8. PubMed ID: 21116070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An old ventricular assist device still working for patients with end-stage heart failure in Japan.
    Morita S
    Circ J; 2011; 75(1):53-4. PubMed ID: 21173502
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function.
    Yoshioka D; Sakaguchi T; Saito S; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Saito T; Daimon T; Ueno T; Kuratani T; Sawa Y
    Circ J; 2012; 76(7):1631-8. PubMed ID: 22484979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary Experience of Extracorporeal Cytokine Hemoadsorption during Left Ventricular Assist Device Implantation in Cardiogenic Shock Patients.
    Pausch J; Mersmann J; Bhadra OD; Barten MJ; Alassar YA; Schulte-Uentrop L; Reichenspurner H; Bernhardt AM
    Thorac Cardiovasc Surg; 2024 Jun; 72(4):266-272. PubMed ID: 36216331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
    Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Implantation of a Left Ventricular Assist Device in Patients With Critical or Impending Cardiogenic Shock an Absolute Contraindication? Looking Back at Our Past Experience Trying to Identify Contraindicative Risk Factors.
    Dell'Aquila AM; Schneider SR; Risso P; Welp H; Glockner DG; Alles S; Sindermann JR; Scherer M
    Artif Organs; 2015 Dec; 39(12):998-1004. PubMed ID: 26011007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
    Teigen LM; John R; Kuchnia AJ; Nagel EM; Earthman CP; Kealhofer J; Martin C; Cogswell R
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
    Tomizawa Y; Tanaka A; Kitahara H; Sakuraba A; Uriel N; Jeevanandam V; Ota T
    Dig Dis Sci; 2018 Jun; 63(6):1518-1524. PubMed ID: 29417325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous aortic valve replacement in left ventricular assist device recipients: single-center experience.
    Dranishnikov N; Stepanenko A; Potapov EV; Dandel M; Siniawski H; Mladenow A; Hübler M; Grauhan O; Weng Y; Krabatsch T; Hetzer R; Kukucka M
    Int J Artif Organs; 2012 Jul; 35(7):489-94. PubMed ID: 22661109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.
    Vest AR; Kennel PJ; Maldonado D; Young JB; Mountis MM; Naka Y; Colombo PC; Mancini DM; Starling RC; Schulze PC
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.